$ cat ./records/gates-foundation-co-founds-cepi-to-cut-vaccine-development-time-t-2017.txt
Gates Foundation Co-founds CEPI to Cut Vaccine Development Time to Under One Year
[RECORD.TXT] · cat --full
The Bill & Melinda Gates Foundation co-founded the Coalition for Epidemic Preparedness Innovations (CEPI) at the World Economic Forum in Davos, committing $100 million over five years alongside the governments of Norway, India, Germany, and Japan, plus the Wellcome Trust — totalling $460 million at launch. CEPI's mission was to reduce vaccine development time from roughly a decade to under twelve months for known epidemic-risk pathogens including MERS, Lassa, Nipah, Ebola, and Zika. CEPI later became a key coordinating body for COVID-19 vaccine development and the COVAX global distribution facility.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Grants Over $1 Million to Ceres Nanosciences for Lyme Disease Diagnostic Technology
Next →
Funds Harvard Solar Geoengineering Research Program
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.